product summary
Loading...
company name :
Invitrogen
other brands :
NeoMarkers, Lab Vision, Endogen, Pierce, BioSource International, Zymed Laboratories, Caltag, Molecular Probes, Research Genetics, Life Technologies, Applied Biosystems, GIBCO BRL, ABgene, Dynal, Affinity BioReagents, Nunc, Invitrogen, NatuTec, Oxoid, Richard-Allan Scientific, Arcturus, Perseptive Biosystems, Proxeon, eBioscience
product type :
antibody
product name :
SARS/SARS-CoV-2 Nucleocapsid Monoclonal Antibody (B46F)
catalog :
MA1-7404
quantity :
100 ug
price :
US 532.00
clonality :
monoclonal
host :
mouse
conjugate :
nonconjugated
clone name :
B46F
reactivity :
SARS-CoV-2
application :
western blot, ELISA, immunohistochemistry, immunocytochemistry
more info or order :
citations: 17
Reference
Zhang W, Golynker I, Brosh R, Fajardo A, Zhu Y, Wudzinska A, et al. Mouse genome rewriting and tailoring of three important disease loci. Nature. 2023;623:423-431 pubmed publisher
Andreu S, Von Kobbe C, Delgado P, Ripa I, Buz xf3 n M, Genesc xe0 M, et al. Dextran sulfate from Leuconostoc mesenteroides B512F exerts potent antiviral activity against SARS-CoV-2 in vitro and in vivo. Front Microbiol. 2023;14:1185504 pubmed publisher
Wu J, Kuan I, Guo J, Hsu W, Tang W, Chan H, et al. SARS-CoV-2 N protein mediates intercellular nucleic acid dispersion, a feature reduced in Omicron. iScience. 2023;26:105995 pubmed publisher
Villadiego J, Garc xed a Arriaza J, Ram xed rez Lorca R, Garc xed a Swinburn R, Cabello Rivera D, Rosales Nieves A, et al. Full protection from SARS-CoV-2 brain infection and damage in susceptible transgenic mice conferred by MVA-CoV2-S vaccine candidate. Nat Neurosci. 2023;26:226-238 pubmed publisher
De Michele M, D Amati G, Leopizzi M, Iacobucci M, Berto I, Lorenzano S, et al. Evidence of SARS-CoV-2 spike protein on retrieved thrombi from COVID-19 patients. J Hematol Oncol. 2022;15:108 pubmed publisher
Macedo S, Pestana A, Santos L, Neves C, Guimar xe3 es S, Duarte Neto A, et al. Detection of SARS-CoV-2 infection in thyroid follicular cells from a COVID-19 autopsy series. Eur Thyroid J. 2022;11: pubmed publisher
Osan J, Talukdar S, Feldmann F, DeMontigny B, Jerome K, BAILEY K, et al. Goblet Cell Hyperplasia Increases SARS-CoV-2 Infection in Chronic Obstructive Pulmonary Disease. Microbiol Spectr. 2022;10:e0045922 pubmed publisher
Lonardi S, Bugatti M, Valzelli A, Facchetti F. Immunohistochemical Detection of SARS-CoV-2 Antigens by Single and Multiple Immunohistochemistry. Methods Mol Biol. 2022;2452:291-303 pubmed publisher
Maronese C, Moltrasio C, Marletta D, Genovese G, Marzano A. Eruptive pyogenic granulomas following coronavirus disease 2019. J Eur Acad Dermatol Venereol. 2022;36:e404-e406 pubmed publisher
Mustroph J, Hupf J, Baier M, Evert K, Brochhausen C, Broeker K, et al. Cardiac Fibrosis Is a Risk Factor for Severe COVID-19. Front Immunol. 2021;12:740260 pubmed publisher
Bortolotti D, Gentili V, Rizzo S, Schiuma G, Beltrami S, Strazzabosco G, et al. TLR3 and TLR7 RNA Sensor Activation during SARS-CoV-2 Infection. Microorganisms. 2021;9: pubmed publisher
Colson A, Depoix C, Dessilly G, Baldin P, Danhaive O, Hubinont C, et al. Clinical and in Vitro Evidence against Placenta Infection at Term by Severe Acute Respiratory Syndrome Coronavirus 2. Am J Pathol. 2021;191:1610-1623 pubmed publisher
Samuel R, Majd H, Richter M, Ghazizadeh Z, Zekavat S, Navickas A, et al. Androgen Signaling Regulates SARS-CoV-2 Receptor Levels and Is Associated with Severe COVID-19 Symptoms in Men. Cell Stem Cell. 2020;27:876-889.e12 pubmed publisher
Osan J, Talukdar S, Feldmann F, Ann DeMontigny B, Jerome K, BAILEY K, et al. Goblet Cell Hyperplasia Increases SARS-CoV-2 Infection in COPD. bioRxiv. 2020;: pubmed publisher
Perez Bermejo J, Kang S, Rockwood S, Simoneau C, Joy D, Ramadoss G, et al. SARS-CoV-2 infection of human iPSC-derived cardiac cells predicts novel cytopathic features in hearts of COVID-19 patients. bioRxiv. 2020;: pubmed publisher
Ko C, Harigopal M, Damsky W, Gehlhausen J, Bosenberg M, Patrignelli R, et al. Perniosis during the COVID-19 pandemic: Negative anti-SARS-CoV-2 immunohistochemistry in six patients and comparison to perniosis before the emergence of SARS-CoV-2. J Cutan Pathol. 2020;47:997-1002 pubmed publisher
Best Rocha A, Stroberg E, Barton L, Duval E, Mukhopadhyay S, Yarid N, et al. Detection of SARS-CoV-2 in formalin-fixed paraffin-embedded tissue sections using commercially available reagents. Lab Invest. 2020;100:1485-1489 pubmed publisher
product information
Product Type :
Antibody
Product Name :
SARS/SARS-CoV-2 Nucleocapsid Monoclonal Antibody (B46F)
Catalog # :
MA1-7404
Quantity :
100 ug
Price :
US 532.00
Clonality :
Monoclonal
Purity :
protein A
Host :
Mouse
Reactivity :
Virus
Applications :
ELISA: 1:20-1:200, Immunohistochemistry: 1:100, Western Blot: 1:10-1:50
Species :
Virus
Clone :
B46F
Isotype :
IgG1
Storage :
4 C
Description :
SARS-CoV-2 Nucleocapsid Protein is associated with nucleic acid. It is the most abundant protein for coronavirus. Because of the strong immunogenicity of coronavirus Nucleocapsid, it is believed that SARS-CoV-2 Nucleocapsid Protein has potential value for the diagnosis of the virus. The SARS-CoV-2 N protein is an abundant RNA-binding protein critical for viral genome packaging, yet the molecular details that involve this process are poorly understood. N protein contains three dynamic disordered regions that house putative transiently-helical binding motifs. The two folded domains interact minimally such that full-length N protein is a flexible and multivalent RNA-binding protein. SARS-CoV-2 causes illnesses ranging from the common cold to severe diseases.
Immunogen :
SARS nucleoprotein preparation.
Format :
Liquid
Applications w/Dilutions :
ELISA: 1:20-1:200, Immunohistochemistry: 1:100, Western Blot: 1:10-1:50
Aliases :
COVID19 Nucleocapsid; COVID-19 nucleocapsid; COVID19 Spike nucleocapsid; SARS-CoV-2 N
more info or order :
company information
Invitrogen
Thermo Fisher Scientific
81 Wyman Street
Waltham, MA USA 02451
https://www.thermofisher.com
800-678-5599
headquarters: USA